Abstract | OBJECTIVES:
Anemia is a direct or indirect consequence of oxidative stress via free radicals on erythrocytes and subsequently on other tissues like liver. Ficus glumosa constitute a rich pharmacologically compound that can prevent or repair oxidative damage. Therefore, this study seeks to evaluate the effect of F. glumosa on phenylhydrazine-induced hemolytic anemia and hepatic damage in rats. METHODS: Twenty-four (24) albino Wistar rats were assigned to four (4) experimental groups (n=6) as follows: Group I (non-anemic control) and Group 2 (anemic control) received normal saline, while Group III and IV (test groups) 200 and 400 mg/kg of aqueous leaf extract of F. glumosa (ALEFG), respectively. All the groups were treated orally (via a cannula) for seven consecutive days. Intraperitoneal (IP) injection of phenylhydrazine (PHZ) at 40 mg/kg for two consecutive days induced hemolytic anemia in group II to IV before treatment. Rats of all groups were anaesthetized and sacrificed 24 h after the last treatment. Blood and liver samples were collected for some hematological indices, liver function test, antioxidant parameter and histological analysis. RESULTS: The LD50 of ALEFG was assessed orally in rats and found to be above 5,000 mg/kg body weight. Significant (p<0.05) decreases in the level of red blood cell (RBC), hemoglobin (HGB) concentrations and packed cell volume (PCV) by 50% after 2 days of PHZ induction, were attenuated by more than 50% after 7 days administration of ALEFG at 200 and 400 mg/kg. The percentage change in body weight increased significantly (p<0.05) after 7 days post PHZ-induced anemia, but those that received oral administration of ALEFG (at 200 and 400 mg/kg) for 7 days increased significantly (p<0.05) by more than 2%, dose-dependently compared to anemic untreated group. Increased level of serum ALT, AST, ALP and GGT in PHZ-induced anemic animals, were significantly (p<0.05) attenuated in the groups that received oral administration of ALEFG (at 200 and 400 mg/kg) for 7 days. Decreased level of catalase (CAT) and superoxide dismutase (SOD) activities with concomitant increase in malondialdehyde (MDA) content from PHZ-induced untreated group, were significantly (p<0.05) mitigated in the rats that received oral administration of ALEFG (at 200 and 400 mg/kg) for 7 days. Histopathological analysis showed that ALEFG could remarkably though not completely mitigated PHZ-induced hepatic damage. CONCLUSIONS:
|
Authors | Azubuike Ikechukwu Okafor, Cecilia Ushike Atsu |
Journal | Journal of complementary & integrative medicine
(J Complement Integr Med)
Vol. 19
Issue 3
Pg. 661-668
(Sep 01 2022)
ISSN: 1553-3840 [Electronic] Germany |
PMID | 35106983
(Publication Type: Journal Article)
|
Copyright | © 2022 Walter de Gruyter GmbH, Berlin/Boston. |
Chemical References |
- Antioxidants
- Hemoglobins
- Phenylhydrazines
- Plant Extracts
- Saline Solution
- phenylhydrazine
- Malondialdehyde
- Catalase
- Superoxide Dismutase
|
Topics |
- Anemia, Hemolytic
(chemically induced, drug therapy, prevention & control)
- Animals
- Antioxidants
(pharmacology, therapeutic use)
- Body Weight
- Catalase
- Ficus
- Hemoglobins
- Malondialdehyde
- Oxidative Stress
- Phenylhydrazines
(adverse effects)
- Plant Extracts
(adverse effects)
- Rats
- Rats, Wistar
- Saline Solution
(adverse effects)
- Superoxide Dismutase
|